Literature DB >> 27522264

Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study.

Gunnar Gudmundsson1, Olof Birna Margretardottir2, Martin Ingi Sigurdsson3, Tamara B Harris4, Lenore J Launer4, Sigurdur Sigurdsson5, Orn Olafsson5, Thor Aspelund6, Vilmundur Gudnason6.   

Abstract

BACKGROUND AND AIMS: Airflow limitation, i.e. reduced forced expiratory volume in 1-s (FEV1), is associated with increased prevalence of atherosclerosis, however, causal mechanisms remain elusive. The objective of the study was to determine if the association between airflow obstruction and markers of atherosclerosis is mediated by systemic inflammation.
METHODS: 1154 subjects from the longitudinal AGES Reykjavik study were included. Population characteristics, systemic inflammation markers from blood (white blood cell counts (WBC) and level of C-reactive protein (CRP)) were compared between patients with and without airflow limitation defined by reduced FEV1 on spirometry. Atherosclerosis burden was quantified by measurements of coronary artery calcium, aortic arch and distal aortic calcification in addition to carotid intimal media thickness (CIMT).
RESULTS: Subjects were split into four groups according to smoking status and whether airflow limitation was present. There was a higher overall burden of atherosclerosis in ever-smokers compared to never-smokers, and in individuals with airflow obstruction compared to individuals without airflow obstruction. After adjusting for population characteristics, Framingham cardiovascular risk factors and markers of systemic inflammation (WBC and CRP), there was a significantly increased aortic arch and distal aorta calcification and higher CIMT measurement in individuals with airflow obstruction compared to individuals without airflow obstruction. After adjusting for population characteristics, Framingham cardiovascular risk factors and markers of systemic inflammation (WBC and CRP), there was a significantly increased aortic arch and distal aorta calcification and higher CIMT measurement in individuals with airflow obstruction compared to individuals without airflow obstruction.
CONCLUSIONS: Systemic inflammation (WBC and CRP) does not appear to mediate the association between airflow limitation and atherosclerosis. Only airflow limitation and not systemic inflammation (WBC and CRP) appears to be an independent predictor of atherosclerosis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular risk factors; Chronic obstructive pulmonary disease; Systemic inflammation

Mesh:

Substances:

Year:  2016        PMID: 27522264      PMCID: PMC5963694          DOI: 10.1016/j.atherosclerosis.2016.07.919

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  26 in total

1.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

2.  Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study.

Authors:  David A McAllister; William MacNee; Daniel Duprez; Eric A Hoffman; Jens Vogel-Claussen; Michael H Criqui; Matthew Budoff; Rui Jiang; David A Bluemke; R Graham Barr
Journal:  COPD       Date:  2011-04       Impact factor: 2.409

3.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

4.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.

Authors:  Morten Dahl; Jørgen Vestbo; Peter Lange; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Am J Respir Crit Care Med       Date:  2006-10-19       Impact factor: 21.405

5.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics.

Authors:  Tamara B Harris; Lenore J Launer; Gudny Eiriksdottir; Olafur Kjartansson; Palmi V Jonsson; Gunnar Sigurdsson; Gudmundur Thorgeirsson; Thor Aspelund; Melissa E Garcia; Mary Frances Cotch; Howard J Hoffman; Vilmundur Gudnason
Journal:  Am J Epidemiol       Date:  2007-03-10       Impact factor: 4.897

6.  Burden of cardiovascular disease in chronic obstructive pulmonary disease.

Authors:  Shikhar Agarwal; Haala Rokadia; Todd Senn; Venu Menon
Journal:  Am J Prev Med       Date:  2014-07-03       Impact factor: 5.043

7.  Systemic inflammation and lung function: A longitudinal analysis.

Authors:  Robert J Hancox; Andrew R Gray; Malcolm R Sears; Richie Poulton
Journal:  Respir Med       Date:  2015-12-19       Impact factor: 3.415

8.  Cerebral infarcts and cognitive performance: importance of location and number of infarcts.

Authors:  Jane S Saczynski; Sigurdur Sigurdsson; Maria K Jonsdottir; Gudny Eiriksdottir; Palmi V Jonsson; Melissa E Garcia; Olafur Kjartansson; Oscar Lopez; Mark A van Buchem; Vilmunder Gudnason; Lenore J Launer
Journal:  Stroke       Date:  2009-01-08       Impact factor: 7.914

9.  Airflow limitation in smokers is associated with subclinical atherosclerosis.

Authors:  Hiroshi Iwamoto; Akihito Yokoyama; Yoshihiro Kitahara; Nobuhisa Ishikawa; Yoshinori Haruta; Kiminori Yamane; Noboru Hattori; Hitoshi Hara; Nobuoki Kohno
Journal:  Am J Respir Crit Care Med       Date:  2008-10-17       Impact factor: 21.405

10.  COPD in never smokers: results from the population-based burden of obstructive lung disease study.

Authors:  Bernd Lamprecht; Mary Ann McBurnie; William M Vollmer; Gunnar Gudmundsson; Tobias Welte; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Eric Bateman; Josep M Anto; Peter Burney; David M Mannino; Sonia A Buist
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

View more
  2 in total

Review 1.  New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.

Authors:  Kurt Brassington; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Clin Sci (Lond)       Date:  2019-04-12       Impact factor: 6.124

2.  Association Between Airflow Limitation and Carotid Intima-Media Thickness in the Japanese Population.

Authors:  Kazuhiko Watanabe; Ayumi Onoue; Hisamitsu Omori; Kenichi Kubota; Minoru Yoshida; Takahiko Katoh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.